ENTITY

Cryofocus Medtech (Shanghai) (6922 HK)

4
Analysis
Health Care • China
Cryofocus Medtech (Shanghai) specializes in the research, development, manufacturing, and sale of minimally invasive interventional medical devices, primarily utilizing cryoablation technology. The company's product portfolio addresses vascular interventional therapy for cardiovascular diseases such as atrial fibrillation and hypertension, as well as natural orifice transluminal endoscopic surgery for urinary, respiratory, and digestive diseases including bladder cancer and gastric cancer. Headquartered in Shanghai, China, the company was founded in 2013.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x